Table 3 The modes of engagement between domestic and exogenous actors and the effect on pharmacogovernance
From: Matching safety to access: global actors and pharmacogovernance in Kenya- a case study
Pharmacogovernance domains | Modes of Engagement | |||||||
|---|---|---|---|---|---|---|---|---|
Advocacy | Autonomy | Collaborative | Consult -ative | Cooper -ative | Delegated | Empowerment | Fragmented | |
Policy, law, regulation (Governing structures, norms, policy instruments, practices, institutional authority) | +/- | +/- | + | + | + | + | Â | Â |
Accountability & Transparency | + | Â | Â | + | Â | Â | Â | Â |
Participation & Representation | Â | Â | Â | +/- | Â | Â | Â | Â |
Equity & Inclusiveness (Distribution of resources for pharmacovigilance) | + | Â | + | Â | Â | Â | Â | Â |
Ethics (Policies to safeguard patient interests) | +/- | Â | Â | Â | Â | Â | Â | Â |
Effectiveness & Efficiency (System integration & communication) | Â | Â | Â | Â | Â | Â | Â | - |
Responsiveness (Risk communication) | Â | Â | Â | + | Â | Â | + | Â |
Intelligence & Information (e-reporting technology, risk communication) | + | Â | + | Â | Â | - | Â | - |
Stakeholder Coordination (Pooled resources, network mobilization, communication network) | + | Â | + | Â | + | Â | Â | _ |